This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aflac Incorporated was formed in 1973 under the laws of the state of Georgia. The company is a general business holding company and oversees the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States (Aflac U.S.) and, effective Apr 1, 2018, through Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan).
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac
by Zacks Equity Research
Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac are included in this Analyst Blog.
Earnings Season Scorecard and Analyst Reports for Thermo Fisher, Philip Morris & General Dynamics
by Sheraz Mian
Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
Down -7.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Aflac (AFL)
by Zacks Equity Research
Aflac (AFL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Aflac's (AFL) Q4 Earnings Miss on Higher Benefits and Claims
by Zacks Equity Research
Aflac (AFL) expects to exceed $1.8 billion in sales in the United States by 2025.
Is Aflac (AFL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Aflac (AFL) and American Express (AXP) have performed compared to their sector so far this year.
Aflac (AFL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Aflac (AFL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Aflac (AFL) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of -14.97% and 14.97%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
4 Accident & Health Insurers to Watch as Underwriting Exposure Increases
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of the Zacks Accident and Health Insurance industry players like AFL, UNM, EIG and TRUP.
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
Can Aflac's (AFL) Q4 Earnings Beat on Strong US Business?
by Zacks Equity Research
Aflac's (AFL) Q4 results are likely to reflect a well-performing U.S. segment, strong net investment income, and a decline in benefits and claims.
What Analyst Projections for Key Metrics Reveal About Aflac (AFL) Q4 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Aflac (AFL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Will Unum Group's (UNM) Beat Streak Continue in Q4 Earnings?
by Zacks Equity Research
Unum Group's (UNM) fourth-quarter results are likely to reflect improved premiums and an increase in net investment income.
Will the Specialty Unit Drive RenaissanceRe (RNR) Q4 Earnings?
by Zacks Equity Research
RenaissanceRe's (RNR) Q4 results are expected to benefit from rate increases in the Property segment and a well-performing specialty business, partly offset by escalating claim expenses.
Why Are Prudent Investors Favoring Aflac (AFL) Shares Now?
by Zacks Equity Research
Aflac's (AFL) product launches and cost-saving initiatives poise the company well for bottom-line growth.
Aflac (AFL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) Upgraded to Buy: Here's Why
by Zacks Equity Research
Aflac (AFL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should iShares Russell Mid-Cap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Will Aflac (AFL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Aflac (AFL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Add Aflac (AFL) to Your Portfolio
by Zacks Equity Research
Higher net investment income, lower expenses and improved profit levels from the U.S. business aid Aflac (AFL) well for growth.
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL
Is Aflac (AFL) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Aflac (AFL) and Assured Guaranty (AGO) have performed compared to their sector so far this year.
Reinsurance Group (RGA) Expands Capacity With Launch of Ruby Re
by Zacks Equity Research
Reinsurance Group (RGA) gets access to alternative capital, expanding its capacity to underwrite risks.
Manulife's (MFC) Unit Inks Partnership With StepStone & Scannell
by Zacks Equity Research
Manulife's (MFC) Manulife Investment Management recapitalizes its portfolio with StepStone and Scannell.
Why You Should Add Blue Owl Capital (OBDC) to Your Portfolio
by Zacks Equity Research
A high-interest rate environment and strong credit performance are expected to poise Blue Owl Capital's (OBDC) results well for growth.